Cargando…
Antidiabetic and vasoprotective activity of lithium: Role of glycogen synthase kinase-3
OBJECTIVES: Lithium is a drug of choice in maniac disorder. Lithium inhibits the glycogen synthase kinase-3 (GSK-3), an enzyme involved in the insulin signalling pathway. Elevated levels of GSK-3 were found in diabetic rats and humans. We aimed to determine the effect of lithium chloride in diabetes...
Autores principales: | Kanzariya, Nilesh R., Patel, Rameshvar K., Patel, Natvar J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153708/ https://www.ncbi.nlm.nih.gov/pubmed/21845000 http://dx.doi.org/10.4103/0253-7613.83116 |
Ejemplares similares
-
Inhibition of glycogen synthase kinase 3 by lithium, a mechanism in search of specificity
por: Chatterjee, Dipashree, et al.
Publicado: (2022) -
Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011) -
Pressurized Hot Water Extraction of Okra Seeds Reveals Antioxidant, Antidiabetic and Vasoprotective Activities
por: Ong, Eng Shi, et al.
Publicado: (2021) -
The Role of Endoplasmic Reticulum Stress-Glycogen Synthase Kinase-3 Signaling in Atherogenesis
por: Huang, Aric, et al.
Publicado: (2018) -
Lithium Enhances Axonal Regeneration in Peripheral Nerve by Inhibiting Glycogen Synthase Kinase 3β Activation
por: Su, Huanxing, et al.
Publicado: (2014)